Today, Zurich Corporate Risk has announced the introduction of Precision CancerCare™ and Second Medical Opinion+ for new policies or existing clients going through a rate retest,...
Zurich Corporate Risk has announced its latest strategic partnership with Reframe Cancer, supporting policyholders who’ve received a new cancer diagnosis.